Farshad Mirzavi

793 total citations
48 papers, 561 citations indexed

About

Farshad Mirzavi is a scholar working on Molecular Biology, Pharmacology and Biomaterials. According to data from OpenAlex, Farshad Mirzavi has authored 48 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Pharmacology and 8 papers in Biomaterials. Recurrent topics in Farshad Mirzavi's work include Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (7 papers) and RNA Interference and Gene Delivery (5 papers). Farshad Mirzavi is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (7 papers) and RNA Interference and Gene Delivery (5 papers). Farshad Mirzavi collaborates with scholars based in Iran, Nigeria and United Kingdom. Farshad Mirzavi's co-authors include Mohammad Soukhtanloo, Mahmoud Reza Jaafari, Roghayyeh Vakili‐Ghartavol, Anvar Soleimani, Mehdi Barati, Safieh Ebrahimi, Mohammad Mashreghi, Seyed Isaac Hashemy, Hammed Tanimowo Aiyelabegan and Jamshid Gholizadeh Navashenaq and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Pharmaceutics.

In The Last Decade

Farshad Mirzavi

44 papers receiving 550 citations

Peers

Farshad Mirzavi

BIOMA

ONCOL

IMMUN

Zhipeng Li China

Banafshe Abadi Iran

Gülce Sarı Türkiye

Sara Nikoofal‐Sahlabadi Iran

Xinrui Li China

Pavan Kumar Chintamaneni India

Aline Pinon France

Wisam Nabeel Ibrahim Qatar

Pegah Varamini Australia

Xiaoyuan Zheng China

Zhipeng Li China

Farshad Mirzavi

190 ×0.9

144 ×1.0

145 ×1.3

BIOMA

41 ×0.6

ONCOL

42 ×0.7

IMMUN

Citations per year, relative to Farshad Mirzavi Farshad Mirzavi (= 1×) peers Zhipeng Li

Countries citing papers authored by Farshad Mirzavi

Since Specialization

Citations

This map shows the geographic impact of Farshad Mirzavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farshad Mirzavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farshad Mirzavi more than expected).

Fields of papers citing papers by Farshad Mirzavi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farshad Mirzavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farshad Mirzavi. The network helps show where Farshad Mirzavi may publish in the future.

Co-authorship network of co-authors of Farshad Mirzavi

This figure shows the co-authorship network connecting the top 25 collaborators of Farshad Mirzavi. A scholar is included among the top collaborators of Farshad Mirzavi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farshad Mirzavi. Farshad Mirzavi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mirzavi, Farshad, et al.. (2025). Combined effects of honey and silver nanoparticles on wound healing in human dermal fibroblast cells. BMC Complementary Medicine and Therapies. 25(1). 446–446.

Ebrahimi, Safieh, et al.. (2025). A Comprehensive Insight Into the Roles of Exosomal circRNAs in Metabolic Syndrome. BioFactors. 51(6). e70053–e70053.

Maleki, Hassan, Hammed Tanimowo Aiyelabegan, Farshad Mirzavi, et al.. (2025). Nanotechnology-mediated precision drug delivery strategies for breast cancer treatment. Biomedicine & Pharmacotherapy. 188. 118224–118224. 6 indexed citations

Aiyelabegan, Hammed Tanimowo, et al.. (2024). Recent advances with erythrocytes as therapeutics carriers. International Journal of Pharmaceutics. 665. 124658–124658. 7 indexed citations

Mirzavi, Farshad, et al.. (2024). Herniarin ameliorates acrylamide-induced neurotoxicity in rat: involvement of neuro-inflammation and acetylcholinesterase. Natural Product Research. 40(5). 1161–1168. 2 indexed citations

Mirzavi, Farshad, et al.. (2024). Urolithin B protects PC12 cells against glutamate-induced toxicity. Molecular Biology Reports. 51(1). 360–360. 3 indexed citations

Askarizadeh, Anis, Mohammad Mashreghi, Elaheh Mirhadi, et al.. (2023). Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy. Cancer Nanotechnology. 14(1). 18–18. 36 indexed citations

Sadeghi, Asie, et al.. (2023). Combination of Alpha-Lipoic Acid and Auraptene Induces Apoptosis and Prevents Proliferation of the Human U-87 Glioblastoma Cells. Revista Brasileira de Farmacognosia. 33(6). 1177–1186. 6 indexed citations

Roshan, Mostafa Karimi, et al.. (2023). Combretastatin A-4 suppresses the invasive and metastatic behavior of glioma cells and induces apoptosis in them: in-vitro study. Medical Oncology. 40(11). 331–331. 7 indexed citations

10.

Mirzavi, Farshad, et al.. (2023). miR-27a/b Level is Associated with ABCA1 Expression and is a Potential PBMC-Based Biomarker for Coronary Artery Disease. International Journal of Cardiovascular Sciences. 36.

11.

Mirzavi, Farshad, et al.. (2023). The Anti-tumor, Anti-oxidative, and Anti-inflammatory Effects of Bee Venom in C26 Colon Carcinoma-Bearing Mice Model. Iranian Journal of Science. 48(1). 69–75. 3 indexed citations

12.

Ebrahimi, Safieh, Farshad Mirzavi, Seyed Isaac Hashemy, et al.. (2023). The in vitro anti‐cancer synergy of neurokinin‐1 receptor antagonist, aprepitant, and 5‐aminolevulinic acid in glioblastoma. BioFactors. 49(4). 900–911. 10 indexed citations

13.

Mirzavi, Farshad, et al.. (2023). Gold-containing liposomes and glucose-coated gold nanoparticles enhances the radiosensitivity of B16F0 melanoma cells via increasing apoptosis and ROS production. Life Sciences. 318. 121495–121495. 25 indexed citations

14.

Soukhtanloo, Mohammad, et al.. (2023). Alpha‐Lipoic Acid, Auraptene, and Particularly Their Combination Prevent the Metastasis of U87 Human Glioblastoma Cells. Evidence-based Complementary and Alternative Medicine. 2023(1). 8618575–8618575. 9 indexed citations

15.

Mirzavi, Farshad, et al.. (2022). Green synthesis of glucose-coated gold nanoparticles for improving radiosensitivity in human U87 glioblastoma cell line. SHILAP Revista de lepidopterología. 4 indexed citations

16.

Mirzavi, Farshad, et al.. (2022). Minocycline attenuates cholinergic dysfunction and neuro-inflammation-mediated cognitive impairment in scopolamine-induced Alzheimer’s rat model. Inflammopharmacology. 30(6). 2385–2397. 19 indexed citations

17.

Ebrahimi, Safieh, Farshad Mirzavi, Seyed Hamid Aghaee‐Bakhtiari, & Seyed Isaac Hashemy. (2022). SP/NK1R system regulates carcinogenesis in prostate cancer: Shedding light on the antitumoral function of aprepitant. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1869(5). 119221–119221. 26 indexed citations

18.

Soleimani, Anvar, Farshad Mirzavi, Sara Nikoofal‐Sahlabadi, et al.. (2022). CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing mice. Scientific Reports. 12(1). 10423–10423. 11 indexed citations

19.

Hooshmand, Sara, Mohammad Soukhtanloo, Farshad Mirzavi, et al.. (2021). Morus nigra L. extract prolongs survival of rats with hepatocellular carcinoma. Phytotherapy Research. 35(6). 3365–3376. 22 indexed citations

20.

Mirzavi, Farshad, Safieh Ebrahimi, Kiarash Ghazvini, Seyed Mahdi Hasanian, & Seyed Isaac Hashemy. (2019). Diagnostic, Prognostic, and Therapeutic Potencies of Circulating miRNAs in Acute Myocardial Infarction. Critical Reviews in Eukaryotic Gene Expression. 29(4). 333–342. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact